New York, India

Pallav Patel

This inventor holds 1 USPTO granted patent. Top assignee: Memorial Sloan Kettering Cancer Center. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pallav Patel. Retrieved from https://idiyas.com/inventor/pallav-patel-wilcv1gg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Pallav Patel

Introduction

Pallav Patel is an accomplished inventor based in New York, Indiana. He has made significant contributions to the field of cancer research, particularly through his innovative work on selective GRP94 inhibitors.

Latest Patents

Pallav Patel holds a patent for "Selective GRP94 Inhibitors and Uses Thereof." This patent represents a crucial advancement in the development of targeted therapies for cancer treatment. He has 1 patent to his name, showcasing his commitment to innovation in medical science.

Career Highlights

Pallav Patel is affiliated with the Memorial Sloan Kettering Cancer Center, a leading institution in cancer research and treatment. His work at this prestigious center allows him to collaborate with some of the brightest minds in the field, further enhancing his contributions to cancer therapy.

Collaborations

One of his notable collaborators is Gabriela Chiosis, who shares a passion for advancing cancer treatment through innovative research. Their partnership exemplifies the collaborative spirit that drives progress in scientific discovery.

Conclusion

Pallav Patel's work in developing selective GRP94 inhibitors highlights his dedication to improving cancer therapies. His contributions to the field are invaluable, and his ongoing research promises to make a significant impact on patient care in the future.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…